Pilot Trial of Supplemental Vitamin A and Nicotinamide (NCT05702398)
Pilot Trial of Supplemental Vitamin A and Nicotinamide and Levels of Blood Vitamin A and Nicotinamide
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to assess the feasibility and safety of oral nicotinamide (NAM; a derivative of vitamin B3 \[niacin\]) and vitamin A in a high-risk population of kidney transplant recipients with a history of skin cancer to generate preliminary data for future cancer prevention clinical trials.
Who can join: Review the eligibility criteria below.
Location: Rhode Island Hospital — Providence, Rhode Island
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Rhode Island Hospital — Providence, Rhode Island
📞 Contact the Study Coordinator
Phone: (401) 863-5895
Email: Eunyoung_Cho@brown.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Skin Cancer
- Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers — Madison, Wisconsin
- In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin — Basking Ridge, New Jersey
- A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers. — Brooklyn, New York
- Undergraduate Skin Cancer Prevention Trial — Salt Lake City, Utah
- Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs — Tampa, Florida
- A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients — Pittsburgh, Pennsylvania
Explore by condition: All Skin Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.